Selective Inhibition of the Hsp90α Isoform-Reference-Cited by-同舟云学术

Selective Inhibition of the Hsp90α Isoform

Published:2021-03-26 Issue:19 Volume:60 Page:10547-10551
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Mishra Sanket J.¹,Khandelwal Anuj¹,Banerjee Monimoy¹,Balch Maurie²,Peng Shuxia²,Davis Rachel E.¹,Merfeld Taylor¹,Munthali Vitumbiko¹,Deng Junpeng²,Matts Robert L.²,Blagg Brian S. J.¹^ORCID

Affiliation:

1. Department of Chemistry and Biochemistry The University of Notre Dame 305 McCourtney Hall Notre Dame IN 46556 USA

2. Department of Biochemistry and Molecular Biology 246 Noble Research Center Oklahoma State University Stillwater OK 74078 USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

General Chemistry,Catalysis

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.202015422

Reference23 articles.

1. HSP90 at the hub of protein homeostasis: emerging mechanistic insights

2. Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1

3. Inhibitors of the heat shock response: Biology and pharmacology

4. Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?

5. The network interaction of the human cytosolic 90kDa heat shock protein Hsp90: A target for cancer therapeutics

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular heat shock protein 90 alpha (eHsp90α)'s role in cancer progression and the development of therapeutic strategies;European Journal of Medicinal Chemistry;2024-11

2. Targeting HSP90 for Cancer Therapy: Current Progress and Emerging Prospects;Journal of Medicinal Chemistry;2024-09-10

3. Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies;Journal of Hematology & Oncology;2024-09-04

4. Small molecule inhibitors targeting heat shock protein 90: An updated review;European Journal of Medicinal Chemistry;2024-09

5. New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer;Journal of Medicinal Chemistry;2024-07-23